Results 51 to 60 of about 13,991 (207)

Dry pleurisy complicating solitary pulmonary nodules caused by Mycobacterium avium: a case report [PDF]

open access: yes, 2015
INTRODUCTION: Mycobacterium avium complex (MAC) lung disease presenting as a solitary pulmonary nodule (MAC-SPN) is often asymptomatic, is more common in middle to old age, and mimics lung cancer or tuberculoma.
Hiroaki Sugiura   +14 more
core   +1 more source

Shedding light on Mycobacterium chelonae and its cutaneous intrusion: A case report

open access: yesJournal of Microbiology and Infectious Diseases
Background: Mycobacterium chelonae, a rapidly proliferating nontuberculous mycobacterium, is renowned for instigating diverse infections, notably those affecting the integumentary system. Despite its pervasive presence in the environment, its propensity
Shankar Lal   +3 more
doaj   +1 more source

Mycobacterium agri Skin Infection in a Previously Healthy Patient: A Case Study

open access: yesInfection and Drug Resistance, 2021
Chengan Xu,1,2 Wenhao Wu,2 Hongyi Pan,3 Tianchen Hui,2 Qingqing Wu,2 Zhewen Zhou,2 Shouhao Wang,2 Wei Zheng,2 Qiaoqiao Yi,2 Hongying Pan2 1The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, People’s ...
Xu C   +9 more
doaj  

Pacemaker site infection caused by Rapidly Growing Nontuberculous Mycobacteria (RGM)

open access: yesBiomedical and Biotechnology Research Journal, 2018
There has been an increased use of cardiac pacemaker device utilization in cardiac patients with a corresponding increase of device-related infections in these patients.
Jhansi Vani Devana   +2 more
doaj   +1 more source

Non-tuberculous mycobacterial pulmonary infections [PDF]

open access: yes, 2017
Submitted by Sandra Infurna (sandra.infurna@ioc.fiocruz.br) on 2019-05-14T13:52:47Z No. of bitstreams: 1 ACC_Caravalho_IOC_2018.pdf: 454431 bytes, checksum: 86468a62313ad15880a6ccff685e3090 (MD5)Approved for entry into archive by Sandra Infurna (sandra.
Agusti   +126 more
core   +4 more sources

What Immunological Defects Predispose to Non-tuberculosis Mycobacterial Infections? [PDF]

open access: yes, 2017
Nontuberculous mycobacteria (NTM) are categorized as one of the large and diverse groups of environmental organisms which are abundant in water and soil.  NTM cause a variety of diseases in humans that mainly affect the lung.
Adcock, IM   +7 more
core  

Multilocus Sequence Typing Scheme versus Pulsed-Field Gel Electrophoresis for Typing Mycobacterium abscessus Isolates [PDF]

open access: yes, 2014
Outbreaks of infections by rapidly growing mycobacteria following invasive procedures, such as ophthalmological, laparoscopic, arthroscopic, plastic, and cardiac surgeries, mesotherapy, and vaccination, have been detected in Brazil since 1998. Members of
Batista Lima, Karla Valeria   +13 more
core   +1 more source

Redefining Therapies for Drug‐Resistant Tuberculosis: Synergistic Effects of Antimicrobial Peptides, Nanotechnology, and Computational Design

open access: yesAdvanced Healthcare Materials, EarlyView.
Antimicrobial peptide (AMP)‐loaded nanocarriers provide a multifunctional strategy to combat drug‐resistant Mycobacterium tuberculosis. By enhancing intracellular delivery, bypassing efflux pumps, and disrupting bacterial membranes, this platform restores phagolysosome fusion and macrophage function.
Christian S. Carnero Canales   +11 more
wiley   +1 more source

Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 2018
Mycobacterium avium complex (MAC) and M. abscessus complex (MABC) comprise the two most important human pathogen groups causing nontuberculous mycobacterial lung disease (NTM-LD). However, there are limited data regarding NTM-LD caused by mixed NTM infections.
Sun Hye, Shin   +10 more
openaire   +2 more sources

Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series

open access: yesBMC Pulmonary Medicine, 2007
Background Current systemic therapy for nontuberculous mycobacterial pulmonary infection is limited by poor clinical response rates, drug toxicities and side effects.
Jacobs Susan S   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy